Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FAAH | O00519 | 1/20 | 0.77 |
| ▸ | MGLL | Q99685 | 1/20 | 0.77 |
| ▸ | CASP3 | P42574 | 5/20 | 0.74 |
| ▸ | KAT2A | Q92830 | 1/20 | 0.60 |
| ▸ | KAT2B | Q92831 | 1/20 | 0.60 |
| ▸ | G6PD | P11413 | 1/20 | 0.59 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29370720 | 0.90 | FAAH (0.88) | FAAHMGLLCASP3KAT2AKAT2B | |
| SCHEMBL16601156 | 0.90 | FAAH (0.88) | FAAHMGLLCASP3KAT2AKAT2B | |
| SCHEMBL203818 | 0.90 | FAAH (0.88) | FAAHMGLLCASP3KAT2AKAT2B | |
| SCHEMBL11278746 | 0.89 | CASP3 (0.74) | FAAHMGLLCASP3KAT2AKAT2B | |
| SCHEMBL3147758 | 0.88 | FAAH (0.97) | FAAHMGLLCASP3KAT2AKAT2B | |
| SCHEMBL24327898 | 0.87 | FAAH (1.00) | FAAHMGLLCASP3KAT2AKAT2B | |
| SCHEMBL1538488 | 0.87 | FAAH (1.00) | FAAHMGLLCASP3KAT2AKAT2B | |
| SCHEMBL8621525 | 0.87 | FAAH (1.00) | FAAHMGLLCASP3KAT2AKAT2B | |
| SCHEMBL11185114 | 0.87 | FAAH (1.00) | FAAHMGLLCASP3KAT2AKAT2B | |
| SCHEMBL1538479 | 0.87 | FAAH (1.00) | FAAHMGLLCASP3KAT2AKAT2B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 69 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12018002-B2 | Certain chemical entities, compositions, and methods | NEUPHARMA, INC (US) | 2024-06-25 | — | — | US | disclosed |
| US-20230043970-A1 | CERTAIN CHEMICAL ENTITIES, COMPOSITIONS, AND METHODS | NEUPHARMA, INC | 2023-02-09 | — | — | US | disclosed |
| WO-2022202958-A1 | NON-AQUEOUS SECONDARY BATTERY POLYMER COMPOSITION AND NON-AQUEOUS SECONDARY BATTERY | 旭化成株式会社 | 2022-09-29 | — | — | WO | disclosed |
| WO-2022131253-A1 | NON-AQUEOUS SECONDARY BATTERY POLYMER COMPOSITION AND NON-AQUEOUS SECONDARY BATTERY | 旭化成株式会社 | 2022-06-23 | — | — | WO | disclosed |
| CN-113036133-A | Polymer composition for nonaqueous secondary battery, and nonaqueous secondary battery | 旭化成株式会社 | 2021-06-25 | — | — | CN | disclosed |
| CN-113036132-A | Polymer composition for nonaqueous secondary battery and nonaqueous secondary battery | 旭化成株式会社 | 2021-06-25 | — | — | CN | disclosed |
| US-20210053044-A1 | Redox Dehydration Coupling Catalysts and Methods Related Thereto | UNIV EMORY (US) | 2021-02-25 | — | — | US | disclosed |
| US-10857140-B2 | K-Ras modulators | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2020-12-08 | — | — | US | disclosed |
| US-9796700-B2 | ERK inhibitors and uses thereof | CELGENE CAR LLC (BM) | 2017-10-24 | — | — | US | disclosed |
| US-20170137406-A1 | ERK INHIBITORS AND USES THEREOF | BRISTOL-MYERS SQUIBB COMPANY | 2017-05-18 | — | — | US | disclosed |
| EP-0871065-A1 | Method for processing a silver halide color photographic light-sensitive material | FUJI PHOTO FILM CO., LTD. (JP) | 1998-10-14 | — | — | EP | disclosed |
| EP-0789275-A1 | Method for processing silver halide color light-sensitive material | FUJI PHOTO FILM CO., LTD. (JP) | 1997-08-13 | — | — | EP | disclosed |
| EP-0747765-A1 | Method of processing silver halide color photographic material | FUJI PHOTO FILM CO., LTD. (JP) | 1996-12-11 | — | — | EP | disclosed |
| EP-0475123-B1 | Use of 2-n-alkyl-1,2-benzisothiazolin-3-ones as technical microbiocides | RIEDEL DE HAEN AG (DE) | 1995-01-04 | — | — | EP | disclosed |
| EP-0331319-B1 | Method for the formation of images | KONISHIROKU PHOTO IND (JP) | 1994-01-26 | — | — | EP | disclosed |
| EP-0475123-A1 | Use of 2-n-alkyl-1,2-benzisothiazolin-3-ones as technical microbiocides | RIEDEL-DE HAEN AKTIENGESELLSCHAFT (DE) | 1992-03-18 | — | — | EP | disclosed |
| US-5059516-A | Spectrally sensitized to near infared region with cyanine dye, (benz)isothiazole and bromo-nitro substituted alkanol | KONICA CORPORATION (JP) | 1991-10-22 | — | — | US | disclosed |
| US-4999282-A | Layer of Spectrally Sensitized Light-Sensitive Silver Halide Emulsion | KONICA CORPORATION (JP) | 1991-03-12 | — | — | US | disclosed |
| EP-0342987-A1 | Silver halide photographic material | KONICA CORPORATION (JP) | 1989-11-23 | — | — | EP | disclosed |
| EP-0331319-A1 | Method for the formation of images | KONICA CORPORATION (JP) | 1989-09-06 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230043970-A1 | CERTAIN CHEMICAL ENTITIES, COMPOSITIONS, AND METHODS | BRAF, PIK3CA, PLK1 | FAAH 2501/4885MGLL 1913/4885CASP3 1080/4885 |
| US-12018002-B2 | Certain chemical entities, compositions, and methods | BRAF, PIK3CA, PLK1 | FAAH 2501/4885MGLL 1913/4885CASP3 1080/4885 |
| US-20170137406-A1 | ERK INHIBITORS AND USES THEREOF | MAP3K20, MAP3K1, MAPK3 | FAAH 3769/4885MGLL 3765/4885CASP3 1691/4885 |
| US-10857140-B2 | K-Ras modulators | KRAS, HRAS, NRAS | FAAH 3260/4885MGLL 3818/4885CASP3 3079/4885 |
| US-20210053044-A1 | Redox Dehydration Coupling Catalysts and Methods Related Thereto | SCLY, TST, SQOR | FAAH 1387/4885MGLL 1210/4885CASP3 745/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.